Skip to content

Clinical trials

Phase 3 Ovarian Neoplasms trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 3 Country / region: Portugal Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20093
20103
20141
20181
20202
20211
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting3
Terminated3
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
Amgen2
AstraZeneca2
Hoffmann-La Roche2
Boehringer Ingelheim1
Medical Research Council1
Memorial Sloan Kettering Cancer Center1
Merck Sharp & Dohme LLC1
Morphotek1
National Cancer Institute, Naples1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms18
Fallopian Tube Neoplasms6
Carcinoma, Ovarian Epithelial4
Breast Neoplasms3
Sarcoma2
Carcinoma, Non-Small-Cell Lung1
Endometrial Neoplasms1
Fibrosarcoma1
Hemangiosarcoma1
Histiocytoma, Malignant Fibrous1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.